Tackling AMR: OECD Says Greater Investment Needed In Later-Stage Drug R&D
Executive Summary
Governments should increase financial resources for novel antimicrobial drug candidates in the later stages of development and tackle shortages of existing, underused antibiotics to combat antimicrobial resistance, says a new report from the OECD.